MANILA, Philippines — Scientists often rely on mathematical models to understand how diseases develop and how biological ...

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...

Dr Raminderpal Singh speaks with Dr Srijit Seal about why specialised AI agents are outperforming general-purpose models in ...

The London company, based at the King's Cross life sciences and tech hub and led by former scientists at AstraZeneca, ...

OpenAI has upgraded GPT-Rosalind for life sciences research, expanding its role from scientific analysis to supporting drug ...

Tempus AI is rated a Strong Buy, leveraging a unique data moat and network effect in healthcare AI. Click here to read an ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...

For most investors, the race to become the world’s most valuable company feels like a contest between Nvidia (NASDAQ:NVDA | ...

(Juan Gaertner/Science Photo Library/Getty Images) Scientists looking to combat Alzheimer's disease may have found two ...

Alzheimer's disease and related dementias are expected to more than double by 2060. As June marks Alzheimer's and Brain ...

Alzheimer's disease and related dementias are expected to more than double by 2060. As June marks Alzheimer's and Brain ...

AI CEOs warn Congress that AI could make bioweapon design easier, pushing for mandatory DNA and RNA screening rules.